Cargando…
Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban
Cirrhosis can occur with the development of portal vein thrombosis (PVT). PVT may aggravate portal hypertension, and it can lead to hepatic decompensation. The international guideline recommends for anticoagulation treatment to be maintained for at least 3 months in all patients with acute PVT. Low-...
Autores principales: | Yang, Hyeyoung, Kim, Seo Ree, Song, Myeong Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266341/ https://www.ncbi.nlm.nih.gov/pubmed/27880998 http://dx.doi.org/10.3350/cmh.2016.0016 |
Ejemplares similares
-
Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis
por: Zhou, Haonan, et al.
Publicado: (2023) -
Transient portal vein thrombosis in liver cirrhosis
por: Qi, Xingshun, et al.
Publicado: (2018) -
Controversies in the Management of Portal Vein Thrombosis in Liver Cirrhosis
por: Mancuso, Andrea
Publicado: (2020) -
Liver Transplantation in Liver Cirrhosis Patients Accompanied by Portal Vein Thrombosis
por: Kim, Bong-Wan
Publicado: (2011) -
Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis
por: Suda, Tsuyoshi, et al.
Publicado: (2020)